Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

33.36
Delayed Data
As of Apr 29
 -1.89 / -5.36%
Today’s Change
25.27
Today|||52-Week Range
263.81
-67.18%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Operating ActivitiesNet Income / Starting Line74.5M-51.5M48.2M--
 
 
 
 
Depreciation407.0M639.8M617.1M--
 
 
 
 
Total Other Cash Flow156.4M176.0M246.6M--
 
 
 
 
Funds From Operations700.4M714.3M824.0M--
 
 
 
 
Funds From/For Other Operating Expenses209.3M299.6M165.5M--
 
 
 
 
Net Cash Flow - Operating Activities491.1M414.6M658.4M--
 
 
 
 
 
InvestingDecrease In Investments17.7M159.1M-1.1M--
 
 
 
 
Capital Expenditures-65.8M-47.3M-43.2M--
 
 
 
 
Net Assets From Acquisitions -795.0M-13.2B581.8M--
 
 
 
 
Other Investing - Uses-10.3B10.3B258.3K--
 
 
 
 
Other Investing - Sources500.0K------
 
 
Net Cash Flow Investing-11.2B-2.7B540.5M--
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings12.0B4.9B-738.5M--
 
 
 
 
Long Term Debt Reduction-1.1B-3.4B194.9M--
 
 
 
 
Net Proceeds Stock Sale1.4B14.3M-65.6M--
 
 
 
 
Common Preferred Redeemed0.00-50.2M2.5M--
 
 
 
Common Dividends----------
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing18.8M6.9M-5.0M--
 
 
 
 
Other Uses - Financing28.2M115.4M168.8M--
 
 
 
 
Net Cash Flow - Financing12.3B1.4B-780.6M--
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-15.1M2.9M-8.8M--
 
 
 
 
 
Net Change In Cash1.6B-906.4M418.4M0.00